InsiderPresident and CEO

Peter Altman Insider Trading Activity

Every SEC Form 4 transaction reported by Peter Altman, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Peter Altman buying or selling?

Peter Altman reported 96 open-market buys ($570.5K) and 0 sells ($0) across 96 Form 4 filings at 1 company — a net buying position of $570.5K.

Source: SEC EDGAR Form 4

What stands out

  • All 96 of Peter Altman's Form 4 filings are for one company, BioCardia, Inc. (BCDA).
  • The most recent Form 4 was accepted on Sep 30, 2026 (18 days ago).
  • In the last 12 months: 21 open-market purchases ($65.6K) and no sales.
  • The largest open-market purchase in the last 12 months was $7.2K of BioCardia, Inc. (BCDA) on Jul 10, 2026. SEC ↗

Key Statistics (as of Sep 30, 2026)

Total Form 4 filings
96
SEC EDGAR
Companies
1
Buys (96)
$570.5K
Sells (0)
$0

Insider sentiment

Net buying

Net insider flow of $570.5K in net buying, filed between Mar 22, 2018 – Sep 30, 2026.

Companies Peter Altman files for

#CompanyForm 4 filings
1BCDABioCardia, Inc.96

Recent Peter Altman transactions

DateTickerRoleTypeSharesValueFiling
Sep 30, 2026BCDAPresident and CEOPurchase1.0K$1.0KSEC ↗
Sep 24, 2026BCDAPresident and CEOPurchase1.9K$2.0KSEC ↗
Sep 5, 2026BCDAPresident and CEOPurchase800$872SEC ↗
Aug 18, 2026BCDAPresident and CEOPurchase5.4K$5.0KSEC ↗
Aug 13, 2026BCDAPresident and CEOPurchase1.9K$1.7KSEC ↗
Jul 30, 2026BCDAPresident and CEOPurchase5.0K$3.9KSEC ↗
Jul 20, 2026BCDAPresident and CEOPurchase500$415SEC ↗
Jul 15, 2026BCDAPresident and CEOPurchase4.3K$3.8KSEC ↗
Jul 10, 2026BCDAPresident and CEOPurchase7.5K$7.2KSEC ↗
Jul 8, 2026BCDAPresident and CEOPurchase5.4K$5.2KSEC ↗
Jun 22, 2026BCDAPresident and CEOPurchase2.3K$2.0KSEC ↗
Jun 9, 2026BCDAPresident and CEOPurchase5.0K$4.3KSEC ↗
May 21, 2026BCDAPresident and CEOPurchase1.7K$1.6KSEC ↗
May 19, 2026BCDAPresident and CEOPurchase5.7K$5.2KSEC ↗
May 15, 2026BCDAPresident and CEOPurchase5.1K$5.2KSEC ↗
Apr 29, 2026BCDAPresident and CEOPurchase5.0K$5.5KSEC ↗
Apr 22, 2026BCDAPresident and CEOPurchase1.0K$1.2KSEC ↗
Mar 27, 2026BCDAPresident and CEOPurchase900$1.1KSEC ↗
Feb 4, 2026BCDAPresident and CEOPurchase5.0K$5.7KSEC ↗
Jan 21, 2026BCDAPresident and CEOPurchase900$1.2KSEC ↗
Dec 17, 2025BCDAPresident and CEOPurchase1.1K$1.4KSEC ↗
Sep 23, 2025BCDAPresident and CEOPurchase48.0K$60.0KSEC ↗
Aug 25, 2025BCDAPresident and CEOPurchase700$1.3KSEC ↗
Aug 13, 2025BCDAPresident and CEOPurchase100$183SEC ↗
Aug 12, 2025BCDAPresident and CEOPurchase400$700.4SEC ↗

Showing the 25 most recent filings of 96. Screen every filing.

Peter Altman insider trading FAQ

Is Peter Altman buying or selling?

Across 96 SEC Form 4 filings, Peter Altman reported 96 open-market purchases totaling $570.5K and 0 sales totaling $0 — a net buying position of $570.5K.

Which companies does Peter Altman file Form 4s for?

Peter Altman has reported insider transactions at 1 company, most often BioCardia, Inc. (BCDA).

How far back does Peter Altman's filing history go?

Trabud holds Peter Altman's SEC Form 4 filings from Mar 22, 2018 – Sep 30, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Peter Altman's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Peter Altman and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener